Left ventricular mass index increase in early renal disease: Impact of decline in hemoglobin

1997 Parfrey, 1990, Outcome of congestive heart failure, dilated cardiomyopathy, hypertrophic hyperkinetic disease and ischemic heart disease in dialysis patients, Am J Nephrol, 10, 213, 10.1159/000168084 Harnett, 1994, Risk factors for the development of left ventricular hypertrophy in a prospectively followed cohort of dialysis patients, J Am Soc Nephrol, 4, 1486, 10.1681/ASN.V471486 Parfrey, 1996, Outcome and risk factors for left ventricular disorders in chronic uraemia, Nephrol Dial Transplant, 11, 1277, 10.1093/ndt/11.7.1277 Dzau, 1993, The role of mechanical and humoral factors in growth regulation of vascular smooth muscle and cardiac myocytes, Curr Opin Nephrol Hypertens, 2, 27, 10.1097/00041552-199301000-00004 Ganten, 1993, Hormones, autocoids, neurotransmitters, and growth factors, Curr Opin Nephrol Hypertens, 2, 1, 10.1097/00041552-199301000-00001 Sen, 1987, Factors regulating myocardial hypertrophy in hypertension, Circulation, 75, I81 Mall, 1988, Myocardial interstitial fibrosis in experimental uremia: Implications for cardiac compliance, Kidney Int, 33, 804, 10.1038/ki.1988.71 Levin, 1996, Prevalent left ventricular hypertrophy in the predialysis population: Identifying opportunities for intervention, Am J Kidney Dis, 27, 347, 10.1016/S0272-6386(96)90357-1 Silberberg, 1990, Regression of left ventricular hypertrophy in dialysis patients following correction of anemia with recombinant human erythropoietin, Can J Cardiol, 6, 1 Foley, 1995, Clinical and echocardiographic disease in patients starting end-stage renal disease therapy, Kidney Int, 47, 186, 10.1038/ki.1995.22 Dahlof, 1992, Reversal of left ventricular hypertrophy in hypertensive patients: A meta-analysis of 109 treatment studies, Am J Hypertens, 5, 95, 10.1093/ajh/5.2.95 Sniderman, 1992, Anemia and left ventricular function in end-stage renal disease, 161 Cockroft, 1976, Prediction of creatinine clearance from serum creatinine, Nephron, 16, 31, 10.1159/000180580 Rutherford, 1992, Chronic ischemic heart disease Devereux, 1987, Left ventricular hypertrophy in hypertension. Prevalence and relationship to pathophysiologic variables, Hypertension, 9, 1153, 10.1161/01.HYP.9.2_Pt_2.II53 Collins, 1989, Reproducibility of left ventricular mass measurements by two-dimensional and M-mode echocardiography, J Am Coll Cardiol, 14, 672, 10.1016/0735-1097(89)90109-5 Gottdiener, 1993, Should echocardiography be performed in individual patients to assess LV regression? Test-retest reliability of echocardiography for measurement of left ventricular mass, J Am Coll Cardiol, 21, 424 Heeson, 1998, A simple nomogram for determination of echocardiographic left ventricular geometry, Am J Cardiol, 82, 485, 10.1016/S0002-9149(98)00363-4 Foley, 1996, The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease, Am J Kidney Dis, 28, 53, 10.1016/S0272-6386(96)90130-4 Vaughan Williams, 1986, Ventricular hypertrophy—Physiologic mechanisms, J Cardiovasc Pharmacol, 8, S12, 10.1097/00005344-198608003-00004 Olivetti, 1989, Capillary growth in anemia-induced ventricular wall remodeling in the rat heart, Circ Res, 65, 1182, 10.1161/01.RES.65.5.1182 Scheel, 1990, Coronary and myocardial adaptations to high altitude in dogs, Am J Physiol, 259, H1173 Olivetti, 1993, Effects of genetic hypertension and nutritional anaemia on ventricular remodelling and myocardial damage in rats, Cardiovasc Res, 27, 1316, 10.1093/cvr/27.7.1316 Tanne, 1994, Ultrastructural and cytochemical changes in the heart of iron-deficient rats, Biochem Pharmacol, 47, 1759, 10.1016/0006-2952(94)90303-4 Re, 1987, Cellular mechanisms of growth in cardiovascular tissue, Am J Cardiol, 60, 104I, 10.1016/0002-9149(87)90469-3 Stockmann, 1988, Reversible induction of right ventricular atriopeptin synthesis in hypertrophy due to hypoxia, Circ Res, 63, 207, 10.1161/01.RES.63.1.207 The SOLVD Investigators, 1992, Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions [published erratum N Engl J Med 327:1768, 1992], N Engl J Med, 327, 685 Pfeffer, 1992, Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators, N Engl J Med, 327, 669, 10.1056/NEJM199209033271001 Schmeider, 1998, Update on reversal of left ventricular hypertrophy in essential hypertension (a meta-analysis of all randomized double blind studies until December 1996), Nephrol Dial Trans, 13, 564, 10.1093/ndt/13.3.564 Vlahakos, 1991, Enalapril-associated anemia in renal transplant recipients treated for hypertension, Am J Kidney Dis, 17, 199, 10.1016/S0272-6386(12)81129-2 Torregrosa, 1994, Efficacy of captopril on posttransplant erythrocytosis. Long-term follow-up, Transplantation, 58, 311, 10.1097/00007890-199408150-00010 Danovitch, 1995, Angiotensin-converting enzyme inhibition in the treatment of renal transplant erythrocytosis. Clinical experience and observation of mechanism, Transplantation, 60, 132, 10.1097/00007890-199507270-00004 Lewis, 1993, The effect of angiotensin-converting enzyme inhibitors on diabetic nephropathy, N Engl J Med, 329, 1459, 10.1056/NEJM199311113292004 Foley, 1995, The prognostic importance of left ventricular geometry in uremic cardiomyopathy, J Am Soc Nephrol, 5, 2024, 10.1681/ASN.V5122024 Harnett, 1995, Cardiac function and hematocrit level, Am J Kidney Dis, 25, S3, 10.1016/0272-6386(95)90673-8 Levy, 1990, Prognostic implication of echocardiographically determined left ventricular mass in the Framingham Heart Study, N Engl J Med, 322, 1561, 10.1056/NEJM199005313222203